Subchapter List for Special Issues

DI 230: Special Issues
 DI 23000: Special Issues
DI 23000.000: Special Issues - Table of Contents
 DI 23001: Capability
DI 23001.000: Capability - Table of Contents
DI 23001.001: Disability Determination Services (DDS) Capability Opinion
DI 23001.005: Disability Determination Services (DDS) Procedures for Developing Capability
DI 23001.015: Disability Determination Services (DDS) Procedures for Documenting Capability
 DI 23003: Contagious Disease
DI 23003.000: Contagious Disease - Table of Contents
DI 23003.001: Contagious Disease Alerts
 DI 23005: Whereabouts Unknown
DI 23005.000: Whereabouts Unknown - Table of Contents
DI 23005.001: Processing Whereabouts Unknown Disability Cases in the Disability Determination Services (DDS)
 DI 23007: Failure to Cooperate
DI 23007.000: Failure to Cooperate - Table of Contents
DI 23007.001: Failure to Cooperate and Insufficient Evidence Definitions
DI 23007.005: Contacting the Claimant, Applicant, Appointed Representative, or Third Party in Claims Involving Failure to Cooperate and Insufficient Evidence
DI 23007.010: A Reasonable Effort to Identify and Involve a Third Party in Claims Involving Failure to Cooperate and Insufficient Evidence
DI 23007.015: Making a Determination Based on the Evidence in the File
 DI 23010: Failure to Follow Prescribed Treatment
DI 23010.000: Failure to Follow Prescribed Treatment - Table of Contents
DI 23010.006: Failure to Follow Prescribed Treatment – General
DI 23010.007: When to Apply Failure to Follow Prescribed Treatment Policy
DI 23010.009: Necessary Conditions to Make a Failure to Follow Prescribed Treatment Determination
DI 23010.011: How to Make a Failure to Follow Prescribed Treatment Determination
DI 23010.013: Development Procedures for a Failure to Follow Prescribed Treatment (FTFPT) Determination
DI 23010.035: Required Written Analysis for a Failure to Follow Prescribed Treatment Determination
DI 23010.040: Adjudication and Notice Procedures for a Failure to Follow Prescribed Treatment Determination
DI 23010.045: Predetermination Notice Language for Failure to Follow Prescribed Treatment Cessations and Adverse Reopenings
 DI 23015: Withdrawal/Claimant Does Not Wish to Pursue Claim
DI 23015.000: Withdrawal/Claimant Does Not Wish to Pursue Claim - Table of Contents
DI 23015.001: Claimant Does Not Wish to Pursue Claim or Requests to Withdraw the Application
 DI 23020: Priority Cases
DI 23020.000: Priority Cases - Table of Contents
DI 23020.001: Priority Cases
DI 23020.010: Potential or Actual Overpayment Cases
DI 23020.015: Presumptive Disability or Blindness and Emergency Advance Payment - Title XVI Only
DI 23020.020: Administrative Law Judge (ALJ) Hearing Cases
DI 23020.025: Appeals Council (AC) Cases
DI 23020.030: Dire Need
DI 23020.035: Inquiries from Public Officials
DI 23020.040: Delayed Cases
DI 23020.045: Terminal Illness (TERI) Cases
DI 23020.050: Disability Determination Services (DDS) Instructions for Identifying, Developing, and Processing Military Casualty/Wounded Warrior (MC/WW) Cases
DI 23020.055: Disability Determination Services (DDS) Claims Instructions for Identifying, Developing, and Processing Veteran’s Affairs 100 Percent Permanent and Total (VAPT) Disability Cases
 DI 23022: Processing Quick Disability Determination (QDD) and Compassionate Allowances (CAL) in the Disability Determination Services (DDS)
DI 23022.000: Processing Quick Disability Determination (QDD) and Compassionate Allowances (CAL) in the Disability Determination Services (DDS) - Table of Contents
DI 23022.010: Compassionate Allowances (CAL) and Quick Disability Determinations (QDD) Fast-Track Processes
DI 23022.030: Identifying and Receipting Compassionate Allowances (CAL) and Quick Disability Determinations (QDD) Cases
DI 23022.040: Compassionate Allowances (CAL) and Quick Disability Determinations (QDD) Fast-Track Case Development
DI 23022.050: Making the Determination in Compassionate Allowances (CAL) or Quick Disability Determinations (QDD) Fast-Track Cases
DI 23022.055: Adding and Modifying Compassionate Allowances (CAL) Status; Removing and Reinstating CAL and Quick Disability Determinations (QDD) Status
DI 23022.060: Disability Determination Services Jurisdiction When a Compassionate Allowances or Quick Disability Determinations Claimant Moves to another State or Leaves the United States
DI 23022.075: Appeals Processing of Compassionate Allowances (CAL) Cases
DI 23022.080: List of Compassionate Allowances (CAL) Conditions
DI 23022.081: 1p36 Deletion Syndrome
DI 23022.082: Adult Heart Transplant Wait List – Status Levels 1-4
DI 23022.085: Acute Leukemia
DI 23022.090: Adrenal Cancer with Distant Metastases or Inoperable, Unresectable or Recurrent
DI 23022.095: Alexander Disease - Child
DI 23022.100: Amyotrophic Lateral Sclerosis (ALS) - ADULT
DI 23022.105: Anaplastic Adrenal Cancer - Adult with Distant Metastases or Inoperable, Unresectable or Recurrent
DI 23022.106: Angiosarcoma
DI 23022.110: Astrocytoma - Grade III and IV
DI 23022.111: Atypical Teratoid/Rhabdoid Tumor
DI 23022.112: Bainbridge-Ropers Syndrome
DI 23022.115: Bladder Cancer with Distant Metastases or Inoperable or Unresectable
DI 23022.117: Blastic Plasmacytoid Dendritic Cell Neoplasm
DI 23022.120: Osteosarcoma, formerly known as Bone Cancer
DI 23022.125: Breast Cancer – with Distant Metastases or Recurrent
DI 23022.127: CACH - Vanishing White Matter Disease - Congenital, Infantile, and Early Childhood Onset Forms
DI 23022.128: Calciphylaxis
DI 23022.130: Canavan Disease
DI 23022.133: CDKL5 Deficiency Disorder
DI 23022.135: Cerebro Oculo Facio Skeletal (COFS) Syndrome
DI 23022.136: Chronic Idiopathic Intestinal Pseudo Obstruction
DI 23022.140: Chronic Myelogenous Leukemia (CML) - Blast Phase
DI 23022.141: Coffin-Lowry Syndrome
DI 23022.143: Congenital Myotonic Dystrophy
DI 23022.144: Charlevoix-Saguenay Spastic Ataxia
DI 23022.145: Creutzfeldt-Jakob Disease (CJD)
DI 23022.146: Desmoplastic Small Round Cell Tumors
DI 23022.150: Ependymoblastoma (Child Brain Cancer)
DI 23022.155: Esophageal Cancer
DI 23022.156: Esthesioneuroblastoma
DI 23022.160: Farber's Disease
DI 23022.163: Fibrolamellar Cancer
DI 23022.165: Friedreich's Ataxia (FRDA)
DI 23022.170: Frontotemporal Dementia (FTD), Pick's Disease - Type A - Adult
DI 23022.175: Gallbladder Cancer
DI 23022.180: Gaucher Disease (GD) - Type 2
DI 23022.181: Giant Axonal Neuropathy
DI 23022.185: Glioblastoma Multiforme (Adult Brain Cancer)
DI 23022.186: GM1 - Gangliosidosis - Infantile & Juvenile Forms
DI 23022.190: Head and Neck Cancers - with Distant Metastasis or Inoperable or Unresectable
DI 23022.191: Hoyeraal-Hreidarsson Syndrome
DI 23022.195: Infantile Neuroaxonal Dystrophy (INAD)
DI 23022.200: Inflammatory Breast Cancer
DI 23022.201: Intracranial Hemangiopericytoma
DI 23022.202: Joubert Syndrome
DI 23022.205: Kidney Cancer - Inoperable or Unresectable
DI 23022.207: Kleefstra Syndrome
DI 23022.210: Krabbe Disease (KD) - Infantile
DI 23022.215: Large Intestine Cancer - with Distant Metastasis or Inoperable, Unresectable or Recurrent
DI 23022.216: Leptomeningeal Carcinomatosis
DI 23022.220: Lesch-Nyhan Syndrome (LNS)
DI 23022.221: Liposarcoma - Metastatic or Recurrent
DI 23022.225: Hepatocellular Carcinoma
DI 23022.226: Malignant Ectomesenchymoma
DI 23022.227: Malignant Renal Rhabdoid Tumor
DI 23022.230: Mantle Cell Lymphoma (MCL)
DI 23022.231: Marshall-Smith Syndrome
DI 23022.233: Megacystis Microcolon Intestinal Hypoperistalsis Syndrome
DI 23022.234: Megalencephaly-Capillary Malformation Syndrome
DI 23022.235: Metachromatic Leukodystrophy (MLD) - Late Infantile
DI 23022.236: Nicolaides-Baraitser Syndrome
DI 23022.238: SYNGAP1-related NSID
DI 23022.240: Niemann-Pick Disease (NPD) - Type A
DI 23022.245: Non-Small Cell Lung Cancer
DI 23022.246: Oligodendroglioma Brain Cancer - Grade III
DI 23022.250: Ornithine Transcarbamylase (OTC) Deficiency
DI 23022.255: Osteogenesis Imperfecta (OI) - Type II
DI 23022.260: Ovarian Cancer - with Distant Metastases or Inoperable or Unresectable
DI 23022.261: Pallister-Killian Syndrome
DI 23022.265: Pancreatic Cancer
DI 23022.266: Pericardial Mesothelioma
DI 23022.270: Peritoneal Mesothelioma
DI 23022.273: Pineoblastoma – Childhood
DI 23022.274: Plasmablastic Lymphoma
DI 23022.275: Pleural Mesothelioma
DI 23022.280: Pompe Disease - Infantile
DI 23022.281: Progressive Bulbar Palsy
DI 23022.282: Prostate Cancer – Hormone Refractory Disease – or with Visceral Metastases
DI 23022.283: Refractory Hodgkin Lymphoma
DI 23022.284: Renpenning Syndrome
DI 23022.285: Rett Syndrome (RTT)
DI 23022.286: Revesz Syndrome
DI 23022.287: Rubinstein-Taybi Syndrome
DI 23022.290: Salivary Cancers
DI 23022.295: Sandhoff Disease
DI 23022.296: Seckel Syndrome
DI 23022.297: Sjögren-Larsson Syndrome
DI 23022.298: Secondary Adenocarcinoma of the Brain
DI 23022.300: Small Cell Cancer of the Large Intestine
DI 23022.305: Small Cell Cancer of the Ovary
DI 23022.310: Small Cell Cancer of the Prostate
DI 23022.311: Small Cell Cancer of the Thymus
DI 23022.315: Small-Cell Cancer of the Female Genital Tract
DI 23022.320: Small Cell Lung Cancer
DI 23022.325: Small Intestine Cancer - with Distant Metastases or Inoperable or Recurrent
DI 23022.326: Soft Tissue Sarcoma - with Distant Metastases or Recurrent
DI 23022.330: Spinal Muscular Atrophy (SMA) - Types 0 and 1
DI 23022.335: Stomach Cancer, with Distant Metastases or Inoperable, Unresectable or Recurrent
DI 23022.337: Superficial Siderosis of the Central Nervous System
DI 23022.340: Anaplastic Thyroid Cancer
DI 23022.341: Taybi-Linder Syndrome
DI 23022.343: Tetrasomy 18p
DI 23022.344: Trisomy 9
DI 23022.345: Ureter Cancer - with Metastases or Inoperable, Unresectable or Recurrent
DI 23022.346: X-Linked Lymphoproliferative Disease
DI 23022.347: X-Linked Myotubular Myopathy
DI 23022.350: Alstrom Syndrome
DI 23022.355: Amegakaryocytic Thrombocytopenia
DI 23022.357: Angioimmunoblastic T-Cell Lymphoma
DI 23022.360: Ataxia Telangiectasia
DI 23022.365: Batten Disease
DI 23022.370: Bilateral Retinoblastoma
DI 23022.373: Congenital Zika Syndrome
DI 23022.374: Costello Syndrome
DI 23022.375: Cri du Chat Syndrome
DI 23022.380: Degos Disease - Systemic
DI 23022.382: Desmoplastic Mesothelioma
DI 23022.385: Early-Onset Alzheimer's Disease
DI 23022.390: Edwards Syndrome (Trisomy 18)
DI 23022.395: Fibrodysplasia Ossificans Progressiva
DI 23022.400: Fukuyama Congenital Muscular Dystrophy
DI 23022.403: Gerstmann-Straussler-Scheinker Disease
DI 23022.405: Hemophagocytic Lymphohistiocytosis - Familial Type (FHLH)
DI 23022.407: Histiocytic Malignancies
DI 23022.410: MPS II
DI 23022.415: MPS I
DI 23022.420: Idiopathic Pulmonary Fibrosis
DI 23022.425: Infantile Neuronal Ceroid Lipofuscinoses
DI 23022.430: Junctional Epidermolysis Bullosa - Lethal Type
DI 23022.435: Late Infantile Neuronal Ceroid Lipofuscinoses
DI 23022.437: Leber Congenital Amaurosis
DI 23022.440: Leigh's Disease
DI 23022.445: Maple Syrup Urine Disease
DI 23022.450: Merosin Deficient Congenital Muscular Dystrophy
DI 23022.453: Microvillus Inclusion Disease – Child
DI 23022.455: Mixed Dementias
DI 23022.457: Mowat-Wilson Syndrome
DI 23022.460: Mucosal Malignant Melanoma
DI 23022.463: Myelodysplastic Syndrome with Excess Blasts
DI 23022.465: Neonatal Adrenoleukodystrophy
DI 23022.468: Neonatal Marfan Syndrome
DI 23022.470: Glutaric Acidemia - Type II
DI 23022.475: Niemann-Pick Disease - Type C
DI 23022.477: NUT Carcinoma
DI 23022.480: Patau Syndrome (Trisomy 13)
DI 23022.481: Pfeiffer Syndrome - Types II and III
DI 23022.482: Pontocerebellar Hypoplasia
DI 23022.483: Primary Peritoneal Cancer
DI 23022.485: Primary Progressive Aphasia
DI 23022.490: Progressive Multifocal Leukoencephalopathy
DI 23022.495: MPS III
DI 23022.496: SCN8A-related Epilepsy with Encephalopathy
DI 23022.500: Spinocerebellar Ataxia
DI 23022.503: Snijders Blok-Campeau Syndrome
DI 23022.505: Subacute Sclerosing Panencephalitis
DI 23022.510: Tay Sachs Disease, Infantile Type
DI 23022.515: Thanatophoric Dysplasia, Type 1
DI 23022.520: Ullrich Congenital Muscular Dystrophy
DI 23022.525: Walker Warburg Syndrome
DI 23022.530: Wolman Disease
DI 23022.535: Zellweger Syndrome
DI 23022.536: Anaplastic Ependymoma
DI 23022.540: Aortic Atresia
DI 23022.543: CIC-rearranged Sarcoma
DI 23022.545: Eisenmenger Syndrome
DI 23022.550: Endomyocardial Fibrosis
DI 23022.555: Heart Transplant Graft Failure
DI 23022.560: Child Heart Transplant Wait List - Status Levels 1A/1B
DI 23022.565: Hypoplastic Left Heart Syndrome
DI 23022.570: Ventricular Assist Device Recipient — Left, Right, or Biventricular
DI 23022.575: Mitral Valve Atresia
DI 23022.580: Cardiac Amyloidosis - AL Type
DI 23022.585: Pulmonary Atresia
DI 23022.586: Sarcomatoid Carcinoma of the Lung—Stages II-IV
DI 23022.587: Sarcomatoid Mesothelioma
DI 23022.590: Single Ventricle
DI 23022.595: Tricuspid Atresia
DI 23022.600: Angelman Syndrome
DI 23022.605: Corticobasal Degeneration
DI 23022.610: Lewy Body Dementia
DI 23022.615: Lowe Syndrome
DI 23022.620: Malignant Multiple Sclerosis
DI 23022.625: Multicentric Castleman Disease
DI 23022.630: Multiple System Atrophy
DI 23022.633: Paraneoplastic Cerebellar Degeneration
DI 23022.635: Paraneoplastic Pemphigus
DI 23022.640: Primary Central Nervous System Lymphoma
DI 23022.643: Posterior Cortical Atrophy
DI 23022.645: Primary Effusion Lymphoma
DI 23022.647: Primary Omental Cancer
DI 23022.650: Progressive Supranuclear Palsy
DI 23022.655: Pulmonary Kaposi Sarcoma
DI 23022.660: ALS/Parkinsonism Dementia Complex
DI 23022.665: Aicardi--Goutieres Syndrome
DI 23022.670: Alobar Holoprosencephaly
DI 23022.675: Alpers Disease
DI 23022.680: Alpha Mannosidosis--Types II and III
DI 23022.685: Carcinoma of Unknown Primary Site
DI 23022.690: Cerebrotendinous Xanthomatosis
DI 23022.695: Child Neuroblastoma—with distant metastases or recurrent
DI 23022.700: Child Lymphoma
DI 23022.704: Cholangiocarcinoma
DI 23022.705: Chondrosarcoma—with multimodal therapy
DI 23022.710: Cornelia de Lange Syndrome--Classic Form
DI 23022.715: Ewing Sarcoma
DI 23022.720: Follicular Dendritic Cell Sarcoma -- metastatic or recurrent
DI 23022.723: FOXG1 Syndrome
DI 23022.725: Fucosidosis -- Type I
DI 23022.730: Galactosialidosis -- Early and Late Infantile Types
DI 23022.735: Glioma - Grade III and IV
DI 23022.745: Hepatoblastoma
DI 23022.750: Histiocytosis Syndromes
DI 23022.755: Hutchinson-Gilford Progeria Syndrome
DI 23022.760: Hydranencephaly
DI 23022.765: Hypocomplementemic Urticarial Vasculitis Syndrome
DI 23022.770: Hypophosphatasia--Perinatal (Lethal) and Infantile Onset Types
DI 23022.775: I Cell Disease
DI 23022.780: Infantile Free Sialic Acid Storage Disease
DI 23022.785: Juvenile Onset Huntington Disease
DI 23022.790: Kufs Disease -- Type A and B
DI 23022.795: Lissencephaly
DI 23022.800: Lymphomatoid Granulomatosis -- Grade III
DI 23022.805: Malignant Brainstem Gliomas -- Childhood
DI 23022.810: Skin Malignant Melanoma with Metastases
DI 23022.815: Mastocytosis Type IV
DI 23022.820: Child Medulloblastoma
DI 23022.825: Merkel Cell Carcinoma – with metastases
DI 23022.827: Metastatic Endometrial Adenocarcinoma
DI 23022.830: Myoclonic Epilepsy with Ragged Red Fibers Syndrome
DI 23022.835: Nephrogenic Systemic Fibrosis
DI 23022.836: Neurodegeneration with Brain Iron Accumulation - Types 1 and 2
DI 23022.840: Obliterative Bronchiolitis
DI 23022.845: Ohtahara Syndrome
DI 23022.850: Orthochromatic Leukodystrophy with Pigmented Glia
DI 23022.853: PACS1 Syndrome
DI 23022.855: Pearson Syndrome
DI 23022.860: Pelizaeus-Merzbacher Disease--Classic Form
DI 23022.865: Pelizaeus-Merzbacher Disease--Connatal Form
DI 23022.870: Peripheral Nerve Cancer – Metastatic or Recurrent
DI 23022.875: Perry Syndrome
DI 23022.877: Pitt Hopkins Syndrome
DI 23022.878: Renal Amyloidosis – AL Type
DI 23022.879: Renal Medullary Carcinoma
DI 23022.880: Rhabdomyosarcoma
DI 23022.885: Rhizomelic Chondrodysplasia Punctata
DI 23022.887: Richter Syndrome
DI 23022.890: Schindler Disease -- Type I
DI 23022.895: Smith Lemli Opitz Syndrome
DI 23022.900: Spinal Nerve Root Cancer – Metastatic or Recurrent
DI 23022.905: Stiff Person Syndrome
DI 23022.910: Tabes Dorsalis
DI 23022.915: Wolf-Hirschhorn Syndrome
DI 23022.920: Xeroderma Pigmentosum
DI 23022.921: Adult Non-Hodgkin Lymphoma
DI 23022.923: Adult Onset Huntington Disease
DI 23022.925: Allan-Herndon-Dudley Syndrome
DI 23022.927: Alveolar Soft Part Sarcoma
DI 23022.929: Aplastic Anemia
DI 23022.931: Beta Thalassemia Major
DI 23022.933: Bilateral Optic Atrophy - Infantile
DI 23022.935: Caudal Regression Syndrome - Types III and IV
DI 23022.937: Child Lymphoblastic Lymphoma
DI 23022.938: Choroid Plexus Carcinoma
DI 23022.939: Congenital Lymphedema
DI 23022.940: Duchenne Muscular Dystrophy - Adult
DI 23022.941: De Sanctis Cacchione Syndrome
DI 23022.943: Dravet Syndrome
DI 23022.945: Endometrial Stromal Sarcoma
DI 23022.947: Erdheim Chester Disease
DI 23022.949: Fatal Familial Insomnia
DI 23022.951: Fryns Syndrome
DI 23022.953: Fulminant Giant Cell Myocarditis
DI 23022.955: Hepatopulmonary Syndrome
DI 23022.957: Hepatorenal Syndrome
DI 23022.959: Jervell and Lange-Nielsen Syndrome
DI 23022.961: Leiomyosarcoma
DI 23022.963: Malignant Gastrointestinal Stromal Tumor
DI 23022.965: Malignant Germ Cell Tumor
DI 23022.967: MECP2 Duplication Syndrome
DI 23022.969: Menkes Disease - Classic or Infantile Onset Form
DI 23022.971: NFU-1 Mitochondrial Disease
DI 23022.973: Nonketotic Hyperglycinemia
DI 23022.975: Peritoneal Mucinous Carcinomatosis
DI 23022.977: Phelan-McDermid Syndrome
DI 23022.979: Retinopathy of Prematurity - Stage V, Bilateral
DI 23022.981: Roberts Syndrome
DI 23022.983: Severe Combined Immunodeficiency -- Childhood
DI 23022.985: Sinonasal Cancer
DI 23022.987: Transplant Coronary Artery Vasculopathy
DI 23022.989: Usher Syndrome - Type I
 DI 23030: Suicide/Homicide
DI 23030.000: Suicide/Homicide - Table of Contents
DI 23030.001: Disability Determination Services (DDS) Procedures for Handling Threats of Suicide or Homicide
DI 23030.005: Disability Determination Services (DDS) Procedures When There is an Immediate Threat of Suicide or Homicide
DI 23030.010: Disability Determination Services (DDS) Procedures When There is No Immediate Threat of Suicide or Homicide
DI 23030.015: Disability Determination Services (DDS) Case Development and Evaluation Procedures for Potential Suicide or Homicide Situations
 DI 23040: Foreign Language Interpreters
DI 23040.000: Foreign Language Interpreters - Table of Contents
DI 23040.001: DDS: Interpreters for Individuals with Limited English Proficiency (LEP) or Individuals Requiring Language Assistance
 DI 23045: Translations of Foreign-Language Documents
DI 23045.000: Translations of Foreign-Language Documents - Table of Contents
DI 23045.001: Translation of Foreign-Language Documents
 DI 23050: Medicare
DI 23050.000: Medicare - Table of Contents
DI 23050.001: Disability Determination Services (DDS) Instructions for Re-entitlement to Disability Benefits and Medicare
DI 23050.005: End Stage Renal Disease Medicare Only for a Dependent Adult Child
 DI 23060: Evidence from Excluded Medical Sources of Evidence
DI 23060.000: Evidence from Excluded Medical Sources of Evidence - Table of Contents
DI 23060.010: Excluded Medical Sources of Evidence – Introduction and Definitions
DI 23060.020: Identifying Excluded Medical Sources of Evidence
DI 23060.030: Evaluating Evidence Furnished by Excluded Medical Sources of Evidence
DI 23060.040: Referring Non-Compliant Excluded Medical Sources of Evidence to the Social Security Administration’s Office of the Inspector General (SSA’s OIG)